Cargando…

Precision antiplatelet therapy for the prevention of ischaemic stroke

Detalles Bibliográficos
Autor principal:	Wang, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067268/ https://www.ncbi.nlm.nih.gov/pubmed/34716284 http://dx.doi.org/10.1136/svn-2021-001383

Ejemplares similares

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis
por: Clarke, Aoibhin, et al.
Publicado: (2022)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020)

Precision antiplatelet therapy
por: Rocca, Bianca, et al.
Publicado: (2023)

Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke
por: Kim, Shina, et al.
Publicado: (2021)

Safety and efficacy of oral antiplatelet for patients who had acute ischaemic stroke undergoing endovascular therapy
por: Huo, Xiaochuan, et al.
Publicado: (2020)

Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
por: Yang, Yingying, et al.
Publicado: (2018)

Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
por: Zhang, Xiao-Guang, et al.
Publicado: (2019)

Antiplatelets in Secondary Stroke Prevention
por: Shulga, Olga, et al.
Publicado: (2011)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice
por: Bonney, Phillip A., et al.
Publicado: (2019)

Diet in Stroke: Beyond Antiplatelets and Statins
por: James, Joe
Publicado: (2019)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015)

The machine learning methods to analyze the using strategy of antiplatelet drugs in ischaemic stroke patients with gastrointestinal haemorrhage
por: Cui, Chaohua, et al.
Publicado: (2023)

Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention
por: Weber, Ralph, et al.
Publicado: (2010)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Acute ischaemic stroke: highlighting the need for early intervention
por: Modi, Girish
Publicado: (2013)

Antiplatelet therapy and bladder tumor resection
por: Goel, Apul, et al.
Publicado: (2018)

ISCHAEMIC STROKE, PREVENTABLE WITH TISSUE ADHESIVE
por: Bothma, Pieter, et al.
Publicado: (2023)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Precision management of brain oedema after acute ischaemic stroke
por: Wu, Simiao, et al.
Publicado: (2022)

Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
por: Kraglund, Kristian Lundsgaard, et al.
Publicado: (2019)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Zhang, Lei, et al.
Publicado: (2021)

Secondary prevention after ischaemic stroke: the ASPIRE-S study
por: Brewer, Linda, et al.
Publicado: (2015)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Individualized Antiplatelet Therapy: A Long Way to Go
por: Han, Ya-Ling
Publicado: (2018)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Antiplatelet therapy for elderly patients with Acute Coronary Syndromes
por: Savonitto, Stefano, et al.
Publicado: (2018)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
Publicado: (2015)

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
por: Wilson, Duncan, et al.
Publicado: (2019)

Post-Ischaemic Immunological Response in the Brain: Targeting Microglia in Ischaemic Stroke Therapy
por: Rawlinson, Charlotte, et al.
Publicado: (2020)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Antiplatelet therapy following TAVI: time to randomise
por: Delewi, R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h1qsumqv02mfiuvgd234e8bv45